CASE REPORT
Published on 04 Mar 2024
Case report: Pembrolizumab as an alternative to atezolizumab following a severe infusion reaction
doi 10.3389/fonc.2024.1273043
- 1,187 views
- 1 citation
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Cancer Immunotherapy – Diagnostic and Therapeutic Strategies to Enhance Antitumoral Efficacies whilst Minimizing Toxicity
Cancer Immunotherapy – Diagnostic and Therapeutic Strategies to Enhance Antitumoral Efficacies whilst Minimizing Toxicity
21k
Total downloads
64k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
SYSTEMATIC REVIEW
Published on 01 Dec 2023
Efficacy, safety, and survival of neoadjuvant immunochemotherapy in operable non-small cell lung cancer: a systematic review and meta-analysis
doi 10.3389/fimmu.2023.1273220
- 2,037 views
- 5 citations
ORIGINAL RESEARCH
Published on 22 Nov 2023
Construction of an acute myeloid leukemia prognostic model based on m6A-related efferocytosis-related genes
doi 10.3389/fimmu.2023.1268090
- 3,700 views
- 4 citations
ORIGINAL RESEARCH
Published on 11 Oct 2023
Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma
doi 10.3389/fimmu.2023.1178060
- 2,692 views
- 4 citations
CASE REPORT
Published on 06 Oct 2023
Case Report: Durable complete response of metastatic hepatocellular carcinoma with asymptomatic hyperamylasemia to combined immunotherapy of anti-cytotoxic T lymphocyte-associated antigen 4 plus anti-programmed cell death-1 antibodies
doi 10.3389/fimmu.2023.1274449
- 1,026 views
ORIGINAL RESEARCH
Published on 29 Sep 2023
Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept
doi 10.3389/fimmu.2023.1249511
- 2,655 views
- 2 citations
ORIGINAL RESEARCH
Published on 15 Sep 2023
Revalidation of the ATTRACTION-4 study in a real-world setting: a multicenter, retrospective propensity score matching study in China
doi 10.3389/fimmu.2023.1264929
- 1,840 views
- 2 citations
ORIGINAL RESEARCH
Published on 06 Sep 2023
Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer
doi 10.3389/fimmu.2023.1188831
- 2,552 views
- 2 citations
CASE REPORT
Published on 07 Jul 2023
Case Report: Chemoimmunotherapy in microsatellite-instability-high advanced goblet cell carcinoma of the colon
doi 10.3389/fimmu.2023.1160586
- 1,852 views
ORIGINAL RESEARCH
Published on 07 Jun 2023
Hypofractionated radiotherapy with immunochemotherapy for extensive-stage small-cell lung cancer
doi 10.3389/fimmu.2023.1175960
- 2,157 views
- 4 citations
ORIGINAL RESEARCH
Published on 06 Jun 2023
CD24-Fc suppression of immune related adverse events in a therapeutic cancer vaccine model of murine neuroblastoma
doi 10.3389/fimmu.2023.1176370
- 2,321 views
- 3 citations
ORIGINAL RESEARCH
Published on 23 May 2023
Targeting KRASG12V mutations with HLA class II-restricted TCR for the immunotherapy in solid tumors
doi 10.3389/fimmu.2023.1161538
- 11,935 views
- 6 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 64kTopic views
- 42kArticle views
- 21kArticle downloads